In this retrospective cohort of ES-SCLC patients treated with first-line platinum-etoposide chemotherapy, some variants in the CD274 (also known as PD-L1) and CTLA4 genes were significantly associated with PFS. The gene discussed is CTLA4; the disease is small cell lung carcinoma.